PracticeUpdate Conference Series World Congress of Dermatology 2019

NOW PBS

LISTED for severe chronic plaque psoriasis 2

THE 1 ST APPROVED IL-23 INHIBITOR WITH 1 INJECTION EVERY 12 WEEKS * AND RESULTS THAT LAST † *First IL-23 inhibitor approved with a 12-weekly injection after an initial injection at weeks 0 and 4 1 † Of 100 mg responders at week 28, 94% and 78% maintained or achieved PASI 75 or 90 respectively out to week 52 1

Before prescribing please refer to primary advertisement for PBS and prescribing information